These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27308732)

  • 21. Classification of endometrial carcinoma: more than two types.
    Murali R; Soslow RA; Weigelt B
    Lancet Oncol; 2014 Jun; 15(7):e268-78. PubMed ID: 24872110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of DNA content assessment in endometrial cancer.
    Mauland KK; Wik E; Salvesen HB
    Cytometry B Clin Cytom; 2014 May; 86(3):154-63. PubMed ID: 24532190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of DNA Ploidy in the ProMisE molecular subgroups of endometrial cancer.
    Proctor L; Pradhan M; Leung S; Cheng A; Lee CH; Soslow RA; Gilks CB; Talhouk A; McAlpine JM; Danielsen HE; Hoang LN
    Gynecol Oncol; 2017 Sep; 146(3):596-602. PubMed ID: 28647100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatments.
    Lheureux S; Oza AM
    Eur J Cancer; 2016 May; 59():99-108. PubMed ID: 27017291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
    Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
    Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should we be more aware of endometrial cancer in adolescents?
    Gałczyński K; Nowakowski Ł; Rechberger T; Semczuk A
    Dev Period Med; 2016; 20(3):169-173. PubMed ID: 27941184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and Management of Endometrial Cancer.
    Braun MM; Overbeek-Wager EA; Grumbo RJ
    Am Fam Physician; 2016 Mar; 93(6):468-74. PubMed ID: 26977831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
    Rodriguez-Freixinos V; Karakasis K; Oza AM
    Curr Oncol Rep; 2016 Apr; 18(4):23. PubMed ID: 26922329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.
    Lin DI; Hecht JL
    Int J Surg Pathol; 2016 Jun; 24(4):297-305. PubMed ID: 26842347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cues on obesity signals, tumor markers and endometrial cancer.
    Daley-Brown D; Oprea-Ilies GM; Lee R; Pattillo R; Gonzalez-Perez RR
    Horm Mol Biol Clin Investig; 2015 Jan; 21(1):89-106. PubMed ID: 25781554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.
    Shih KK; Garg K; Levine DA; Kauff ND; Abu-Rustum NR; Soslow RA; Barakat RR
    Gynecol Oncol; 2011 Oct; 123(1):88-94. PubMed ID: 21742371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic counseling and cascade genetic testing in Lynch syndrome.
    Hampel H
    Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape.
    Jamieson A; Barroilhet LM; McAlpine JN
    Cancer; 2022 Aug; 128(15):2853-2857. PubMed ID: 35657171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ECGene: A Literature-Based Knowledgebase of Endometrial Cancer Genes.
    Zhao M; Liu Y; O'Mara TA
    Hum Mutat; 2016 Apr; 37(4):337-43. PubMed ID: 26699919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Behavior and Treatment of Endometrial Cancer.
    Gupta D
    Adv Exp Med Biol; 2017; 943():47-74. PubMed ID: 27910064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining a mutational signature for endometrial cancer screening and early detection.
    Costas L; Palomero L; Benavente Y; Guardiola M; Frias-Gomez J; Pavón MÁ; Climent M; Martinez JM; Barahona M; Salinas M; Pineda M; Bianchi I; Reventós J; Capellà G; Diaz M; Vidal A; Piulats JM; Ponce J; Brunet J; Bosch FX; Matias-Guiu X; Alemany L; de Sanjosé S; Aytés Á;
    Cancer Epidemiol; 2019 Aug; 61():129-132. PubMed ID: 31238232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomas.
    Wong A; Kuick CH; Wong WL; Tham JM; Mansor S; Loh E; Jain S; Vikas NN; Tan SH; Chan SH; Li ST; Chew SH; Hong W; Ngeow J
    Gynecol Oncol; 2016 Apr; 141(1):113-20. PubMed ID: 26748215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The gynecological surveillance of women with Lynch syndrome in Sweden.
    Tzortzatos G; Andersson E; Soller M; Askmalm MS; Zagoras T; Georgii-Hemming P; Lindblom A; Tham E; Mints M
    Gynecol Oncol; 2015 Sep; 138(3):717-22. PubMed ID: 26177554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
    Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
    Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.